Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2414266
Max Phase: Preclinical
Molecular Formula: C27H24Cl3N7
Molecular Weight: 552.90
Molecule Type: Small molecule
Associated Items:
ID: ALA2414266
Max Phase: Preclinical
Molecular Formula: C27H24Cl3N7
Molecular Weight: 552.90
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)n1nnnc1C(Nc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1)c1ccc(Cl)c(Cl)c1
Standard InChI: InChI=1S/C27H24Cl3N7/c1-27(2,3)37-26(34-35-36-37)25(16-4-11-21(29)22(30)14-16)33-19-8-6-18(7-9-19)32-23-12-13-31-24-15-17(28)5-10-20(23)24/h4-15,25,33H,1-3H3,(H,31,32)
Standard InChI Key: MBELAKXCNCRMKS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 552.90 | Molecular Weight (Monoisotopic): 551.1159 | AlogP: 7.88 | #Rotatable Bonds: 6 |
Polar Surface Area: 80.55 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 6.47 | CX LogP: 7.02 | CX LogD: 6.98 |
Aromatic Rings: 5 | Heavy Atoms: 37 | QED Weighted: 0.22 | Np Likeness Score: -1.77 |
1. Pandey S, Agarwal P, Srivastava K, Rajakumar S, Puri SK, Verma P, Saxena JK, Sharma A, Lal J, Chauhan PM.. (2013) Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents., 66 [PMID:23792317] [10.1016/j.ejmech.2013.05.023] |
Source(1):